Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_702df4cbea412e9b8c7b024224152bf7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2017-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b592b13d0d1662b902b480abe28e88f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8fa66f549e8a584ef52d9a0f6bdf10c |
publicationDate |
2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2018048151-A |
titleOfInvention |
EPH receptor expression in tumor stem cells |
abstract |
[PROBLEMS] To develop a new and more specific treatment for a brain tumor. In particular, the provision of inhibitors for the growth and proliferation of glioblastoma. A ephrin receptor used in the treatment of brain tumors, which is a precursor of EphA2 having a specific amino acid sequence and can be used for the treatment and prevention of brain tumor recurrence after surgery. Inhibits. [Selection figure] None |
priorityDate |
2010-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |